Kristopher D. Brown

Kristopher D. Brown

he/him/his
Partner
合伙人
Kristopher D. Brown

Kristopher Brown is a partner in the firm’s Life Sciences group. Mr. Brown negotiates and structures private equity and venture capital financing transactions. He also advises on corporate and transactional matters for numerous financial and corporate strategic investors as well as emerging growth companies in the life sciences, healthcare, financial and technology sectors.

Mr. Brown has experience in the full range of complex commercial transactions, including mergers and acquisitions, divestitures, public offerings, licensing transactions, the formation of investment partnerships, and the creation of strategic and collaborative alliances and joint ventures. Practicing for more than 20 years, Mr. Brown has advised on more than 250 transactions in the life sciences sector alone. In addition, he counsels investors, management executives, and boards of directors on governance and regulation issues and securities law matters.

Mr. Brown is listed as a “Life Sciences Star” and a “U.S. Transactional Rising Star” by LMG Life Sciences and has been listed as a recommended lawyer for life sciences and capital markets: equity and global offerings by The Legal 500, where he was cited as being “highly skilled and committed” and noted for the “strength of his client relationships.”

Prior to joining Goodwin in 2018, Mr. Brown was a partner at Dechert LLP.

宗科睿律师是高赢国际律师事务所生命科学业务部合伙人。宗律师专注于谈判和构建私募股权和风险资本融资交易。他还为众多财务和公司型战略投资者以及生命科学、医疗保健、金融和技术领域的新兴成长型公司提供公司和交易方面的咨询。

宗律师在处理各类复杂的商业交易方面拥有丰富的经验,包括并购、资产剥离、公开发行、许可交易、建立投资合作伙伴关系,以及构建战略合作联盟和合资企业。宗律师执业20多年,仅在生命科学领域就为超过250宗交易提供咨询。此外,他还就公司治理和监管问题以及证券法事宜向投资者、管理层和董事会提供建议。

宗律师被《LMG生命科学》评为年度生命科学领域之星美国交易领域的后起之秀,并获得《法律500强》生命科学和资本市场领域股票和全球发行方面的重点推荐律师,同时称赞宗律师:业务水平精湛、专注投入,以及特别注重与客户的合作关系

在2018年加入高赢之前,宗律师是德杰律师事务所的合伙人。

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Mr. Brown has advised on award-winning life sciences deals, including:

Capital Markets

  • Calliditas Therapeutics in its upsized $90 million IPO on Nasdaq in the U.S.
  • Bicycle Therapeutics in its $60 million IPO on Nasdaq in the U.S.
  • Advaxis, Inc. in multiple follow-on financings on Nasdaq
  • Zealand Pharma in its $75 million IPO on Nasdaq in the U.S.*
  • Forward Pharma in its $221 million IPO on Nasdaq in the U.S., which won M&A Advisor’s “Healthcare/Life Sciences Sector Deal of the Year” award*

M&A

  • Johnson & Johnson in the sale of its BabyCenter business to Everyday Health Group
  • Johnson & Johnson in the sale of one of its drug product lines to Baxter
  • Johnson & Johnson in the transfer of collaboration rights and assets to Pharma Mar
  • Remedy Pharmaceuticals’ sale to Biogen, in a transaction which received a ”Commended” ranking at the Financial Times North American Innovative Lawyers 2017 Awards*
  • Lazada Group on the $1 billion sale of a controlling stake in the company to Alibaba, which was named “M&A Deal of the Year: Southeast Asia” at The Asian Lawyer’s 2017 Asia Legal Awards.*
  • AM-Pharma’s sale of a minority interest in the company to Pfizer Inc. and related option payment, which was a finalist for the 2015 Scrip Awards*

Licensing & Collaborations

  • Johnson & Johnson in its strategic alliance with Apple to deploy the Apple Watch to detect atrial fibrillation
  • Johnson & Johnson in its partnership with Verily (f/k/a Google Life Sciences) to innovate advanced surgical robots, which won LMG’s “2015 Collaboration Deal of the Year”*

Royalty Monetizations

  • Barings in the purchase of certain rights from George Washington University related to the license by GWU of its vasoconstrictor drug to La Jolla Pharmaceutical Company
  • Onxeo in the $7.5 million royalty and milestone monetization from SWK Holdings of Onxeo’s oncology drug to treat refractory peripheral T cell lymphoma
  • Zealand Pharma in the $205 million royalty and milestone monetization from Royalty Pharma of Zealand’s GLP-1 diabetes franchise
  • Zealand Pharma’s monetization of certain royalty rights under its license agreement with Sanofi-Aventis, which was a finalist for the 2015 Scrip Awards*

Venture Capital

  • Johnson and Johnson UK Treasury Company Limited as lead investor of the $1.3 billion Series B financing of Grail, Inc., which was named LMG Life Sciences 2017 “Impact Deal of the Year”*

* Denotes experience prior to joining Goodwin.

宗律师曾为以下获奖的生命科学交易提供建议,包括:

  • 强生公司将其孕婴保健公司BabyCenter业务出售给Everyday Health Group
  • Bicycle Therapeutics在美国纳斯达克上市
  • Advaxis, Inc.在纳斯达克多次后续融资
  • 强生公司向百特出售其一条药品生产线
  • 强生公司将合作权利和资产转让给Pharma Mar
  • 强生公司与苹果公司结成战略联盟,通过苹果手表来提供房颤检测
  • Zealand Pharma与Royalty Pharma of Zealand就糖尿病特许经营权达成了2.05亿美元货币化交易
  • Remedy Pharmaceuticals出售给渤健公司,这项交易获得了“2017年金融时报北美创新律师奖” *
  • Johnson and Johnson UK Treasury Company Limited作为主要投资者参与Grail, Inc., 13亿美元B轮融资,这项交易获得了《LMG生命科学》“2017年最具度影响力交易” *
  • Forward Pharma A/S在美国纳斯达克上市,这项交易获得了M&A顾问公司的“年度医疗保健/生命科学行业交易奖”*
  • 强生公司与Verily(原名为谷歌生命科学公司)联合设计先进的手术机器人,这项交易获得了《LMG生命科学》 “2015年度最佳合作交易”*
  • AM-Pharma’s将其少数股权及相关的期权出售给辉瑞,这项交易入围行业瞩目的2015 SCRIP年度大奖*
  • 根据与赛诺菲-安万特的许可协议,Zealand Pharma’s将其特许权货币化,这项交易也入围2015 SCRIP年度大奖*

此外,宗律师曾为电子商务公司Lazada Group向阿里巴巴出售10亿美元公司控股权项目提供了建议,该交易获得2017年亚洲律师协会颁发的亚洲法律大奖“年度最佳并购交易:东南亚”。*

* 加入高赢之前的经验

Professional Activities

Mr. Brown is a member of the American Bar Association, the New York State Bar Association, and the Association of the Bar of the City of New York.

专业活动

 宗律师是美国律师协会和纽约市律师协会的成员。

Professional Experience

Mr. Brown is a member of Brown University’s Advisory Council on Entrepreneurship, and is also a member of the National Advisory Council for, and served until 2018 as the pro bono outside general counsel to DonorsChoose.org. In addition, Mr. Brown serves on the investor board of Venture for America, the advisory board of Lyfebulb, as a Blueprint Health mentor, and as a member of the Nordic Mentor Network for Entrepreneurship, or NOME.

专业经验

宗律师是布朗大学创业咨询委员会的成员,也是国家咨询委员会的成员,并在2018年之前担任DonorsChoose.org的公益外部总顾问。此外,宗律师还是美国风险投资公司的投资者委员会、Lyfebulb的顾问委员会、Blueprint Health 导师以及北欧企业家导师网络(NOME)的成员。

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 1992
Boston University School of Law

(magna cum laude)

A.B., 1989
Brown University

(magna cum laude, Phi Beta Kappa)

教育背景

法学博士, 1992
Boston University School of Law

(magna cum laude)

A.B., 1989
Brown University

(magna cum laude, Phi Beta Kappa)

Admissions

Bar

New York
Massachusetts
California

Courts

U.S. District Court for the Southern District of New York

执业资格

司法区

纽约州
马萨诸塞州
加利福尼亞州

法庭

Profile Image
Get In Touch
Kontakt
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师